Rheumatic mitral stenosis is often associated with thrombus formation in the left atrium (LA), especially in patients with atrial fibrillation. Although thrombus can occur anywhere within the LA, the most common site is the left atrial appendage. Therefore, it is important to carefully screen the entire LA during perioperative transesophageal echocardiography to exclude thrombus.
A 35-year-old female presented with NYHA Grade 2/3 dyspnea and palpitations with an increase in severity for 1 month. After evaluation, she was diagnosed with severe rheumatic mitral stenosis (MS) (mitral valve area 0.9 cm 2 ) with a giant left atrium (LA) (70 cm × 82 cm) and moderate pulmonary hypertension (pulmonary artery systolic pressure 40 mmHg). However, no LA thrombus was appreciated during preoperative transthoracic echocardiography (TTE) study. The patient was in atrial fibrillation (AF) and had unfavorable valve anatomy for balloon mitral valvuloplasty. She was posted for elective mitral valve replacement surgery.
During an intraoperative transesophageal echocardiography (TEE), unexpectedly, a large thrombus was seen in the roof of the LA extending onto the interatrial septum (IAS) without involving the left atrial appendage (LAA) [ Figure 1 ]. This finding was confirmed surgically after opening the LA. The size and organized nature of the thrombus in the presence of severe MS prevented embolization into the systemic circulation. This clot was missed by the initial preoperative TTE partly due to poor acoustic windows, the unusual location, and probable initial small size. Surgery was uneventful with complete thrombus removal and implantation of a St. Jude 25 mm mechanical mitral valve prosthesis. The patient recovered well without any neurologic dysfunction in the postoperative period.
Watch Out for Left Atrial Roof Thrombus

Discussion
Rheumatic MS is associated with LA thrombus in patients in sinus rhythm (3%-13%) [1, 2] and markedly increases in AF (~33%). [3] The presence of LA thrombus carries a risk of systemic embolization and neurologic morbidity.
TEE is a sensitive diagnostic modality to detect LA thrombus, particularly in the LAA. [4] It has a 97% sensitivity, 100% specificity, positive predictive value of 100%, and a negative predictive value of 99.6% to detect a thrombus. [5] Small thrombus can be detected using contrast echocardiography which provides contrast opacification within the cardiac chambers to delineate the "filling defect" of the thrombus. [6] Manjunath et al. [7] proposed an echocardiographic classification of LA thrombus based on its location, extension, and mobility as follows: This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
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The incidence of LA thrombus according to types has been reported in a few small studies as Type Ia (64%-76%), Type Ib (9%-32%), Type IIa (3.6%-12.5%), and Type IIb (2%). [7, 8] However, in this case, the LA thrombus shared characteristics of both Types IIb and III with Grade 0−1+ spontaneous echo contrast (SEC).
The risk factors for LA thrombus formation in MS include AF, previous embolic episodes, age >40 years, LA dimension >4.5 cm, and LAA emptying velocity <20 cm/s. [7] However, MS patients in sinus rhythm are also at risk of LA clot formation with an inferosuperior LA dimension >6.9 cm, mean mitral gradient >18 mmHg, and SEC Grade >3. [8] This case again highlights the utility of an intraoperative TEE in diagnosing unreported and missed cardiac pathologies during preoperative screening.
Conclusion
Patients with MS are at increased risk of thrombus formation anywhere within the LA irrespective of the cardiac rhythm. Accordingly, screening of the entire LA during intraoperative TEE is of paramount importance.
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